Edward Ukamaka¹*, Nnodim Johnkennedy¹, Chinedu-Eleonu PO², Ikem Promise Amarachi¹ and Nsonwu Magnus³

¹Department of Medical Laboratory Science, Faculty of Health Science, Imo State University, Owerri, Nigeria
²Department of Public Health, Faculty of health Science, Imo State University, Owerri Imo State, Nigeria
³Department of Optometry, Faculty of health Science, Imo State University, Owerri Imo State, Nigeria

*Corresponding Author: Edward Ukamaka, Department of Medical Laboratory Science, Faculty of Health Science, Imo State University, Owerri, Nigeria.

Received: July 31, 2023; Published: Sepetember 29, 2023

Abstract

A class of disorders known as cardiometabolic diseases includes heart attack, stroke, diabetes, insulin resistance, and non-alcoholic fatty liver disease. These conditions are all common yet frequently preventable. People around the world are becoming more likely to develop one or more of these illnesses at some point in their lives. The four main causes of this increase are acknowledged to be smoking, not exercising enough, consuming large amounts of alcohol, and maintaining an unhealthy diet. Tackling cardiometabolic disorders is crucial for the future health of our entire communities because of the enormous socioeconomic costs associated with these conditions.

Keywords: Perspective; Cardiometabolic Diseases; Heart Attack; Stroke; Diabetes; Insulin Resistance

References

1. Valenzuela PL., et al. “Obesity and the risk of cardiometabolic diseases”. Nature Reviews Cardiology 20 (2023): 475-494.
2. Srivastava AK. “Challenges in the treatment of cardiometabolic syndrome”. Indian Pharmacology2 (2012): 155-156.
3. Castro JP., et al. “Cardiometabolic syndrome: pathophysiology and treatment”. Current Hypertension Reports 5 (2003): 393-401.
4. Gill H., et al. “The key role of insulin resistance in the cardiometabolic syndrome”. American Journal of the Medical Sciences 330 (2005): 290-294.
5. Kelli HM., et al. “Cardiometabolic syndrome: a global epidemic”. Journal of Diabetes and Metabolism 6 (2015): 1-14.
6. Leiter LA., et al. “Cardiometabolic risk in Canada: a detailed analysis and position paper by the cardiometabolic risk working group”. Canadian Journal of Cardiology2 (2011): e1-33.
7. Freisling H., et al. “Lifestyle factors and risk of multimorbidity of cancer and cardiometabolic diseases: a multinational cohort study”. BMC Medicine 18 (2020): 5
8. Xu X., et al. “Progression of diabetes, heart disease, and stroke multimorbidity in middle-aged women: a 20-year cohort study”. PLoS Medicine 15 (2018): e1002516.
9. Anne-Karien M de Waard., et al. “Selective prevention of cardiometabolic diseases: activities and attitudes of general practitioners across”. Europe European Journal of Public Health1 (2019): 88-93.
10. Di Angelantonio E., et al. “Association of cardiometabolic multimorbidity with mortality”. JAMA 314 (2015): 52-60.
11. Chenjie Xu and Zhi Cao. “Cardiometabolic diseases, total mortality, and benefits of adherence to a healthy lifestyle: a 13-year prospective UK Biobank study”. Journal of Translational Medicine234 (2022): 55-57.
12. Miranda JJ., et al. “Understanding the rise of cardiometabolic diseases in low- and middle-income countries”. Nature Medicine11 (2019): 1667-1679.

Citation

Citation: Edward Ukamaka., et al.. “Perspective of Cardiometabolic Diseases". Acta Scientific Clinical Case Reports 4.10 (2023): 26-28.

Copyright

Copyright: © 2023 Edward Ukamaka., et al.. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.